ArticleMethods in molecular biology (Clifton, N.J.)2025
Comparative Profiling of Regulatory Modules as a Tool for Identifying the Transcription Factor Network Linked to Leukemogenesis.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dynamic gene expression program of hematopoiesis is controlled by a complex network of regulatory modules consisting of transcription factors, chromatin modifiers, and genomic organizers. Genetic abnormalities or changes in the levels of these factors can disrupt normal development and often lead to malignant transformation into leukemic cells. Open chromatin regions are hallmarks of regulatory elements that can be profiled by their susceptibility to DNase I and Tn5 transposase. Genome-wide comparative profiling of open chromatin regions of normal and malignant cells can identify differentially induced regulatory elements and their associated regulatory modules in disease development. We provide an optimized bioinformatics pipeline for the processing of assay for transposase-accessible chromatin sequencing (ATAC-seq) and comparative profiling of open chromatin regions. The identified differentially induced open chromatin regions are used to investigate the changes in molecular networks that drive disease development through integrative analysis with other multi-OMICS data. Here, we demonstrate the robust application of this methodology to compare murine B-cell acute lymphoblastic leukemia cells with wild-type control, which can be applied to any two biological conditions. This integrative computational methodology can also be used for comparative profiling of genome-wide functional element screening methods such as DNaseI hypersensitive sites seq (DNase-seq) and chromatin immunoprecipitation seq (ChIP-seq).
Indexed as
Identifiers
40029523What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.